Dissemin is shutting down on January 1st, 2025

Published in

American Heart Association, Stroke, Suppl_1(49), 2018

DOI: 10.1161/str.49.suppl_1.143

Links

Tools

Export citation

Search in Google Scholar

Abstract 143: Stroke Impairs Endothelial Cells Through Downregulation of Programed Death Ligand-1 Expression

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Introduction: Stroke triggers a robust inflammatory response, allowing leukocytes to cross the blood brain barrier. T cells infiltrate in an antigen-independent manner early after injury, leading to additional neuronal injury. The pro-inflammatory cytokine, interferon-gamma (IFNγ), upregulates programed death ligand-1 (PD-L1) expression. Engagement of PD-L1 and programed death-1 (PD-1) “calls off” the cytolytic activity of infiltrated T cells. The immunosuppressive activity of PD-L1 is modulated by ubiquitination and glycosylation. Glycogen synthase kinase 3β (GSK3β) interacts with PD-L1 and induces degradation of PD-L1. To date, the role of PD-L1 in endothelial cells (ECs) remains elusive. Hypothesis: PD-L1 in EC reduces neuroinflammation via protection of microvascular integrity. Methods: Human brain ECs, HBEC-5i, were subjected to IFNγ treatment in normal or oxygen-glucose deprivation (OGD) conditions. Western blot, Fluorescence-activated cell sorting analysis, PD-1 binding assays and an in vitro T cell killing assay were performed to investigate EC viability and PD-L1 function. Male mice (12 weeks) were subjected to a 60-minute middle cerebral artery occlusion (MCAO) and given either vehicle or GSK3β inhibitor VIII (4 mg/kg). We examined PD-L1 expression, blood vessel integrity and T cell activation in brain tissue using anti-PD-L1, p-GSK3β, CD31, and Granzyme B antibodies for immunohistochemistry (IHC). Results: IFNγ strongly induced PD-L1 expression in ECs. However, when ECs were exposed to OGD, IFNγ-mediated PD-L1 upregulation was compromised (from 48.9% to 31.4%). PD-L1 binding affinity of EC was also reduced after OGD (from 33.1% to 1.3%). Consistently, human (n=22) and mice (n=6) brain IHC staining found lower levels of PD-L1 and p-GSK3β in ECs and higher expression of Granzyme B in stroke samples compared to controls (p<0.05). MCAO mice treated with GSK3β inhibitor VIII showed higher PD-L1 expression and smaller infarcts. Conclusion: This study reveals a protective role of PD-L1 in ECs during early brain injury. Activation of GSK3β by stroke destabilized endothelial PD-L1. Thus, stabilizing PD-L1 or preventing downregulation of PD-L1 may maintain microvascular integrity and reduce neuroinflammation after stroke.